The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin
- 1 July 1996
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 3 (7) , 579-589
- https://doi.org/10.1016/s1074-5521(96)90149-0
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Transcription-Coupled Repair Deficiency and Mutations in Human Mismatch Repair GenesScience, 1996
- The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeastMutation Research/DNA Repair, 1996
- Binding of Mismatched Microsatellite DNA Sequences by the Human MSH2 ProteinScience, 1994
- DNA Mismatch Binding and Incision at Modified Guanine Bases by Extracts of Mammalian Cells: Implications for Tolerance to DNA Methylation DamageBiochemistry, 1994
- Enhancement of CDDP Cytotoxicity by Caffeine Is Characterized by Apoptotic Cell DeathExperimental Cell Research, 1994
- Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cellsFEBS Letters, 1993
- Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationBiochemistry, 1985
- Use of antibodies to probe the stereochemistry of antitumor platinum drug binding to DNABiochemistry, 1983
- Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II)Biochemistry, 1983
- Mismatch correction at O6-methylguanine residues in E. coli DNANature, 1982